Vertex Pharmaceuticals Inc / Ma

MARK SHEPTOFF FINANCIAL PLANNING, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

10,246

Value ($000)

4,645

Weight

2.2%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	4,645	2.2%	10,246	12/31/2025
2025 Q3	11/13/2025	4,218	2.0%	10,771	9/30/2025
2025 Q2	8/6/2025	4,795	2.6%	10,771	6/30/2025